WalterJamesDurkinMD

Oncology • Daytona Beach, FL

Physician

Join to view full profile

Dr. Durkin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Durkin's full profile

Already have an account?

Office
303 N Clyde Morris Blvd
Halifax Regional Oncology Center
Daytona Beach, FL 32114
Phone+1 386-254-4212

Fax+1 386-254-4214
Is this information wrong?

Education & Training

University of Southern California/LAC+USC Medical CenterFellowship, Medical Oncology, 1975 - 1976
University of Southern California/LAC+USC Medical CenterResidency, Internal Medicine, 1974 - 1975
Ascension Illinois/Saint Joseph (Chicago)Residency, Internal Medicine, 1973 - 1973
Ascension Illinois/Saint Joseph (Chicago)Residency, Internal Medicine, 1972 - 1972
McGaw Medical Center of Northwestern UniversityResidency, Surgery, 1971 - 1971
Loyola University Chicago Stritch School of MedicineClass of 1971

Certifications & Licensure

CA State Medical License 1973 - Present
FL State Medical License 1979 - 2025
OK State Medical License 2012 - 2024
IL State Medical License 1972 - 1987
AL State Medical License Active through 1986
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification ARIA Medical Oncology EMR, Varian Medical Systems, 2013
Top MD Consumers Checkbook

Clinical Trials

PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score Start of enrollment: 2012 May 01
Completed

Publications & Presentations

PubMed

17 citations
Antibodies to mouse mammary tumor virus-related antigen in sera of patients with breast carcinoma.
Milan Tomana, Adriena H. Kajdos, William Niedermeier, Walter J. Durkin, Jiri Mestecky> ;Cancer. 1981 Jun 1
52 citations
A Methodological Approach to the Prediction of Anticancer Drug Effect in Humans
Walter J. Durkin, Vithal K. Ghanta, Dolores W. Davis, Raymond N. Hiramoto, Charles M. Balch> ;Cancer Research. 1979 Feb 1
40 citations
5‐Fluorouracil in hepatocellular carcinoma. Report of twenty‐one cases
John S. Link, Joseph R. Bateman, Warren S. Paroly, Walter J. Durkin, Robert L. Peters> ;Cancer. 1977 May 1
Melanoma in a patient treated for psoriasis.
Durkin, W., Sun, N., Link, J., Paroly, W., Schweitzer, R.> ;South Med J. 1978 Jun
Effect of chronic peritoneal fluid eosinophilia on peritoneal membrane function.
Ejaz, A. A., Zabaneh, R. I., Ridlon, T., Durkin, W., Siddiqui, T.> ;J Pak Med Assoc. 1998 Aug
Comparison of survival. Chemotherapeutically treated and untreated older patient with acute myeloid leukemia.
Siddiqui, T., Durkin, W. J., Conley, N. S., Doughney, K. B., Favis, G. R., Weiss, R., Smith, A. E.> ;J Fla Med Assoc. 1994 Jul
Fixed drug eruption from pamabrom.
Nedorost, S., Taylor, J. S., Camisa, C., Tomecki, K. J., Helm, T., Durkin, W. J.> ;Cleve Clin J Med. 1991 Jan 01
Cancer drug therapy.
Durkin, W. J.> ;Prim Care. 1992 Dec
Bleomycin (NSC-125066) therapy of responsive solid tumors.
Durkin, W. J., Pugh, R. P., Jacobs, E., Sadoff, L., Pajak, T., Bateman, J. R.> ;Oncology. 1976
Treatment of advanced lymphomas with bleomycin (NSC-125066).
Durkin, W. J., Pugh, R. P., Solomon, J., Rosen, P., Pajak, T. F., Bateman, J. R.> ;Oncology. 1976
Join now to see all